MCUIF News Alert Miraculins Inc (MCUIF) 0.1550 09/27/2014 19

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Miraculins Inc (MCUIF) 0.1550 $MCUIF

Miraculins Completes Share Consolidation
Marketwire - Fri Jan 24, 3:31PM CST
Miraculins Inc. (TSX VENTURE: MOM) ("Miraculins" or the "Company" , a medical diagnostic company focused on acquiring, developing and commercializing diagnostic and risk assessment technologies for unmet clinical needs, announces that, further to its news release of January 13, 2014, the TSX Venture Exchange has approved the consolidation of the Company's issued and outstanding common shares ("Common Shares" on the basis of ten pre-consolidation Common Shares for every one post-consolidation Common Share and the Company has proceeded with the consolidation. Effective at the opening of the market on January 27, 2014, Miraculins' shares will commence trading on the TSX Venture Exchange on a consolidated basis under the new CUSIP number 60462L207. The Company's name and trading symbol will not change as a result of the consolidation. The Company will have approximately 12,492,010 Common Shares issued and outstanding as a result of the consolidation. Letters of transmittal with respect to the consolidation will be sent to registered shareholders by CST Trust Company, the Company's Transfer Agent.

Miraculins Releases CEO Letter to Shareholders
Marketwire - Mon Jan 20, 6:19AM CST
Miraculins Inc. (TSX VENTURE: MOM), ("Miraculins" or the "Company" a medical diagnostic company focused on acquiring, developing and commercializing diagnostic and risk assessment technologies for unmet clinical needs, today issues the following letter to shareholders from Company President & CEO Christopher Moreau:

Miraculins Announces First Closing of Private Placement Offering
Marketwire - Fri Sep 20, 4:06PM CDT
Miraculins Inc. (TSX VENTURE: MOM), (the "Company" , a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, is pleased to announce the first close of a private placement offering (the "Offering" with aggregate gross proceeds to the Company of $430,000 from the sale of 7,166,667 units ("Units" at a price of $0.06 per Unit. Each Unit is comprised of one common share of the Company (a "Share" and one half of one Share purchase warrant (a "Warrant" .

Miraculins' SCOUT DS(R) Non-Invasive Diabetes Screening Test to be Piloted by Major Canadian Supermarket Chain
Marketwire - Mon Sep 16, 5:31AM CDT
Miraculins Inc. (TSX VENTURE: MOM), ("Miraculins" or the "Company" a medical diagnostic company focused on acquiring, developing and commercializing diagnostic and risk assessment technologies for unmet clinical needs, today announces that a major Canadian supermarket chain, in collaboration with Pear Healthcare Solutions ("Pear" , a leading provider of in-pharmacy health screening and educational services to the Canadian pharmacy community, will be conducting a special pilot of the Miraculins' SCOUT DS(R) Non-Invasive Diabetes Screening technology as part of a series of pharmacy diabetes clinics to be held at 35 store locations in fall 2013.

Miraculins Announces Private Placement Offering
Marketwire - Thu Sep 12, 5:31AM CDT
Miraculins Inc. (TSX VENTURE: MOM), ("Miraculins" or the "Company" a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, today announces a non-brokered private placement offering (the "Offering" of up to 16,666,666 units ("Units" at a price of $0.06 per Unit for gross proceeds of up to $1,000,000. Each Unit will be comprised of one common share of the Company (a "Share" and one half of one Share purchase warrant. Each whole warrant (a "Warrant" will entitle the holder to purchase one Share at a price of $0.10 per Share for a period of 12 months from the date the Warrant is issued.

Miraculins Announces Publication of Comprehensive Review Article on Skin Cholesterol and Its Link to Increased Cardiovascular Risk
Marketwire - Mon Sep 09, 5:31AM CDT
Miraculins Inc. (TSX VENTURE: MOM), ("Miraculins" or the "Company" a medical diagnostic company focused on acquiring, developing and commercializing diagnostic and risk assessment technologies for unmet clinical needs, announces today the publication of a review article entitled "The Relationship Between Skin Cholesterol Testing and Parameters of Cardiovascular Risk: A Systematic Review" authored by A. Yashar Tashakkor, MD, and G. B. John Mancini, MD, FRCPC of the Department of Medicine (Division of Cardiology), University of British Columbia.

Miraculins Announces H-E-B Store Locations for Its PreVu(R) Skin Cholesterol Test Pilot in Texas
Marketwire - Thu Sep 05, 5:31AM CDT
Miraculins Inc. (TSX VENTURE: MOM), ("Miraculins" or the "Company" , a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, announces today the 20 store locations where H-E-B, the #1 food retailer in South and Central Texas and the State's largest private company, will be conducting a pilot launch of the Company's PreVu(R) Non-Invasive Skin Cholesterol Point of Care (POC) Test this fall. This is the first such launch of the product into the United States.

Miraculins Announces Issuance of Independent Analyst's Research Report from New York Based RB Milestone Group
Marketwire - Thu Aug 22, 1:35PM CDT
Miraculins Inc. (TSX VENTURE: MOM), ("Miraculins" or the "Company" a medical diagnostic company focused on acquiring, developing and commercializing diagnostic and risk assessment technologies for unmet clinical needs, announces today that an independent analyst's research report has been issued by New York based RB Milestone Group, LLC ("RB Milestone" .

Miraculins Highlights New Peer-Reviewed Publications on SCOUT DS(R)
Marketwire - Mon Aug 19, 5:31AM CDT
Editors note: There is one photo associated with this press release.

Miraculins Re-Appoints Pear Healthcare Solutions to Distribute Scout DS(R) to Canadian Retail Pharmacy/Grocery Market
Marketwire - Fri Aug 16, 5:31AM CDT
Miraculins Inc. (TSX VENTURE: MOM), ("Miraculins" or the "Company" a medical diagnostic company focused on acquiring, developing and commercializing diagnostic and risk assessment technologies for unmet clinical needs, announces today that it has re-appointed Pear Healthcare Solutions Inc. ("Pear" , a leading provider of in-pharmacy health screening and education services, as the distributor for the SCOUT DS(R) Non-Invasive Diabetes Test Technology to the Canadian retail pharmacy/grocery market. Pear is also the Company's Canadian distributor for the PreVu(R) Non-Invasive Skin Cholesterol Point-of-Care (POC) Test to the same market segment.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 25

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 142

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
Litmus Gets $475 Million as Music Rights Mature Further

Updated Category News Views 115

Music royalties just got another serious pile of institutional money, and Litmus is holding the shovel. The company announced roughly $475 million of new capital commitments from Carlyle and investment funds managed by KKR, a notable vote of confidence in a platform that did not even exist before 2022. This is not some celebrity vanity vehicle buying a famous chorus and...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 150

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 81

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 177

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 98

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 115

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 83

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Specialty Chemicals Need Demand Before Capacity Bets

Updated Category News Views 96

Empty reactor space does not get filled because everybody suddenly loves reshoring. SOCMA's 2027 Contract Manufacturing Outlook makes that stubborn fact hard to dodge: nearly 70% of surveyed respondents expect North American manufacturing activity to rise over the next three years, yet 79.5% say stronger, more predictable customer demand is critical before future...

Continue Reading

Top 5 Most Recently Viewed Articles

New Terminal One Partners with Plaza Premium to Elevate Travel

Updated Category News Views 234

New Terminal One & Plaza Premium Group Collaboration The New Terminal One at JFK International Airport has joined forces with Plaza Premium Group (PPG), a leading name in airport hospitality, to create two state-of-the-art lounges. Together, they aim to transform the travel experience at this vital international hub, covering close to 14,000 square feet and promising...

Continue Reading
Market Update: S&P 500 Fluctuates After Holiday Trading

Updated Category News Views 337

S&P 500 Experiences Mixed Results in Light Trading The recent trading session saw the S&P 500 close on a flat note after a day of ups and downs, all in the backdrop of lower-than-usual trading volumes, a trend typical of the holiday breakout. As of the market close, the S&P 500 had dipped by 0.1%, while the NASDAQ Composite mirrored this decrease. In contrast, the Dow...

Continue Reading
Brand Engagement Network Expands Horizons with Cataneo Acquisition

Updated Category News Views 104

Brand Engagement Network Expands Strategic Capabilities Jackson, Wyo. – brand Engagement Network, Inc. (NASDAQ: BNAI) has recently made headlines by agreeing to acquire a German media technology powerhouse, Cataneo Gmbh. This acquisition not only highlights BEN's commitment to growth but also demonstrates its ambition to transform how brands use AI to engage with their...

Continue Reading
Metagenomi Showcases Advanced Adenine Base Editors for Gene Therapy

Updated Category News Views 195

Introducing Metagenomi's Innovative Adenine Base Editors Metagenomi has unveiled its cutting-edge Adenine Base Editors (ABEs) at a recent event, highlighting their impressive capabilities in genome editing. These novel tools achieved over 95% targetability in gene modification, demonstrating exceptional performance and efficiency. Key Highlights from the Presentation...

Continue Reading
Streamlining IT Procurement: SysAid Launches on AWS Marketplace

Updated Category News Views 49

SysAid Now Accessible via AWS Marketplace SysAid, a leading Enterprise and IT Service Management solution provider, has made an exciting announcement regarding its availability on AWS Marketplace. This curated digital catalog is designed to simplify the process of discovering, procuring, and deploying software solutions. With AWS Marketplace having over 290,000 active...

Continue Reading